Ellevest, Inc. Eli Lilly & CO Transaction History

Ellevest, Inc.

$1.8 Billion
Q3 2024

A detailed history of Ellevest, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Ellevest, Inc. holds 3,800 shares of LLY stock, worth $2.85 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

3,800

Previous 3,762 1.01%

Holding current value

$2.85 Million

Previous $3.41 Million 1.17%

% of portfolio

0.19%

Previous 0.2%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$772.14 - $960.02 $29,341 - $36,480	38 Added 1.01%	3,800 $3.37 Million
Q2 2024 Aug 14, 2024	BUY	$724.87 - $909.04 $189,191 - $237,259	261 Added 7.46%	3,762 $3.41 Million
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $51,521 - $68,928	87 Added 2.55%	3,501 $2.72 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $310,387 - $365,905	591 Added 20.94%	3,414 $1.99 Million
Q3 2023 Nov 09, 2023	BUY	$434.7 - $599.3 $34,776 - $47,944	80 Added 2.92%	2,823 $1.52 Million
Q2 2023 Aug 09, 2023	BUY	$350.74 - $468.98 $59,625 - $79,726	170 Added 6.61%	2,743 $1.29 Million
Q1 2023 May 04, 2023	BUY	$310.63 - $364.82 $24,229 - $28,455	78 Added 3.13%	2,573 $883,000
Q4 2022 Feb 03, 2023	BUY	$321.55 - $374.67 $69,133 - $80,554	215 Added 9.43%	2,495 $912,000
Q3 2022 Nov 02, 2022	BUY	$296.48 - $337.87 $64,336 - $73,317	217 Added 10.52%	2,280 $737,000
Q2 2022 Jul 18, 2022	BUY	$278.73 - $327.27 $414,471 - $486,650	1,487 Added 258.16%	2,063 $669,000
Q1 2022 Apr 19, 2022	SELL	$234.69 - $291.66 $275,291 - $342,117	-1,173 Reduced 67.07%	576 $165,000
Q4 2021 Jan 24, 2022	BUY	$224.85 - $279.04 $272,743 - $338,475	1,213 Added 226.31%	1,749 $483,000
Q3 2021 Oct 19, 2021	BUY	$221.6 - $272.71 $9,528 - $11,726	43 Added 8.72%	536 $124,000
Q2 2021 Jul 13, 2021	SELL	$180.55 - $233.54 $215,576 - $278,846	-1,194 Reduced 70.78%	493 $113,000
Q1 2021 May 03, 2021	BUY	$164.32 - $212.72 $20,540 - $26,590	125 Added 8.0%	1,687 $315,000
Q4 2020 Feb 04, 2021	BUY	$130.46 - $172.63 $52,575 - $69,569	403 Added 34.77%	1,562 $264,000
Q3 2020 Oct 26, 2020	BUY	$146.22 - $169.13 $7,895 - $9,133	54 Added 4.89%	1,159 $172,000
Q2 2020 Jul 06, 2020	BUY	$136.42 - $164.18 $57,023 - $68,627	418 Added 60.84%	1,105 $181,000
Q1 2020 Apr 13, 2020	BUY	$119.05 - $147.35 $25,119 - $31,090	211 Added 44.33%	687 $95,000
Q4 2019 Feb 05, 2020	BUY	$106.92 - $132.43 $27,906 - $34,564	261 Added 121.4%	476 $63,000
Q3 2019 Oct 08, 2019	BUY	$106.79 - $116.16 $2,135 - $2,323	20 Added 10.26%	215 $24,000
Q2 2019 Aug 20, 2019	BUY	$110.79 - $129.32 $11,743 - $13,707	106 Added 119.1%	195 $22,000
Q4 2018 Jan 25, 2019	BUY	$105.9 - $118.64 $9,425 - $10,558	89 New	89 $10,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $713B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.

Account